EP 1289532 A2 20030312 - LOW CARBOHYDRATE COMPOSITIONS, KITS THEREOF, AND METHODS OF USE
Title (en)
LOW CARBOHYDRATE COMPOSITIONS, KITS THEREOF, AND METHODS OF USE
Title (de)
ZUSAMMENSETZUNGEN MIT NIEDRIGEM KOHLEHYDRATGEHALT, KITS DAVON SOWIE VERWENDUNG
Title (fr)
COMPOSITIONS A BASSE TENEUR EN GLUCIDES, NECESSAIRES ET METHODES D'UTILISATION DE CES COMPOSITIONS
Publication
Application
Priority
- US 0117716 W 20010601
- US 58651400 A 20000602
- US 75996501 A 20010112
Abstract (en)
[origin: WO0193831A2] The present invention relates to compositions, kits, and methods utilized for the treatment of joint dysfunction, bone dysfunction, and / or inflammation. The composition utilized herein are useful for those mammals experiencing painful or debilitating joint, bone, or inflammatory conditions, and are particularly suited for mammals which are diabetic or at risk for diabetes, as well as those desiring or requiring conveniently dosed chondroprotective compositions having low carbohydrate content, low caloric value and / or having a low glycemic index. In particular, the present compositions comprise: a) a chondroprotective agent selected from gelatin, cartilage, aminosugars, glycosaminoglycans, methylsulfonylmethane, precursors of methylsulfonylmethane, S-adenosylmethionine, and mixtures thereof; b) a sweetening agent other than glucose, dextrose, sucrose, and fructose; and c) at least about 10 % water, by weight of the composition. In an alternative embodiment of the present invention, the present compositions comprise: a) a chondroprotective agent selected from gelatin, cartilage, aminosugars, glycosaminoglycans, methylsulfonylmethane, precursors of methylsulfonylmethane, S-adenosylmethionine, salts thereof, and mixtures thereof; and b) a sweetening agent other than glucose, dextrose, sucrose, and fructose;wherein the composition is substantially free of aspartame. Other compositions of the present invention comprise a chondroprotective agent selected from gelatin, cartilage, aminosugars, glycosaminoglycans, methylsulfonylmethane, precursors of methylsulfonylmethane, S-adenosylmethionine, and mixtures thereof, and have a low carbohydrate content, as defined herein.
IPC 1-7
A61K 31/7008; A61K 9/08; A61K 31/726; A23L 2/00; A23L 1/305; A23L 1/304
IPC 8 full level
A61K 9/08 (2006.01); A61K 9/00 (2006.01); A61K 31/10 (2006.01); A61K 31/7008 (2006.01); A61K 31/7076 (2006.01); A61K 31/726 (2006.01); A61K 35/32 (2006.01); A61K 35/60 (2006.01); A61K 38/17 (2006.01); A61K 47/26 (2006.01); A61P 19/02 (2006.01); A61P 19/08 (2006.01); A61P 29/00 (2006.01)
CPC (source: EP)
A61K 9/0095 (2013.01); A61K 47/26 (2013.01); A61P 19/02 (2017.12); A61P 19/08 (2017.12); A61P 29/00 (2017.12)
Citation (search report)
See references of WO 0193831A2
Citation (examination)
- JP H1160478 A 19990302 - YAKULT HONSHA KK
- JP 2000004836 A 20000111 - MEIJI MILK PROD CO LTD
- JP 2000281562 A 20001010 - TAISHO PHARMA CO LTD
- JP 2000159691 A 20000613 - TAISHO PHARMA CO LTD
- JP 2000290199 A 20001017 - TAISHO PHARMA CO LTD
- JP 2000175648 A 20000627 - SANEI GEN FFI INC
- Retrieved from the Internet <URL:http://ific.nisgroup.com/publications/brochures/upload/sucralosebrochure.pdf> [retrieved on 20051116]
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0193831 A2 20011213; WO 0193831 A3 20020425; AU 6973001 A 20011217; BR 0111292 A 20030610; CA 2408610 A1 20011213; CN 1438892 A 20030827; EP 1289532 A2 20030312; JP 2003535120 A 20031125; MX PA02011939 A 20030422
DOCDB simple family (application)
US 0117716 W 20010601; AU 6973001 A 20010601; BR 0111292 A 20010601; CA 2408610 A 20010601; CN 01810982 A 20010601; EP 01948259 A 20010601; JP 2002501404 A 20010601; MX PA02011939 A 20010601